Cabaletta Bio is a startup based in All, most recent round IPO, 2 tracked investors.
Cabaletta Bio is a company headquartered in All. Its most recent tracked round is IPO. Brouky records 2 investors associated with the company.
Cabaletta Bio discovers and develops targeted cell therapy product candidates to potentially cure patients with autoimmune diseases. Learn about our CAAR T cell products.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.